Evidence map›Paper›PMID 40950400›Full record

ArticleFrontiers in cell and developmental biology2025

Correction: PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathway.

Huafu Li, Chunming Wang, Linxiang Lan, Wenhui Wu, Ian Evans, E Josue Ruiz, Leping Yan, Zhijun Zhou, Joaquim M Oliveira, Rui L Reis and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Huafu Li *Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Chunming Wang *Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Linxiang Lan *Adult Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom.
Wenhui Wu *Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Ian EvansAdult Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom.
E Josue RuizAdult Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom.
Leping YanCenter of Scientific Research, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Zhijun ZhouDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Joaquim M Oliveira3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, University of Minho, Guimarães, Portugal.
Rui L Reis3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, University of Minho, Guimarães, Portugal.
Zhenran HuDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Wei ChenDigestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Axel BehrensAdult Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom.
Yulong HeDigestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Changhua ZhangDigestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fcell.2021.719192.].

Indexed as

gastric cancerhomologous recombinationL-OHP resistanceorganoidPARP1 inhibitors

Identifiers

PMID40950400
PMCPMC12424430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.